1337918-83-8
1337918-83-8 structure
- Name: Vazegepant
- Chemical Name: N-{(2R)-3-(7-Methyl-1H-indazol-5-yl)-1-[4-(1-methyl-4-piperidinyl)-1-piperazinyl]-1-oxo-2-propanyl}-4-(2-oxo-1,2-dihydro-3-quinolinyl)-1-piperidinecarboxamide
- CAS Number: 1337918-83-8
- Molecular Formula: C36H46N8O3
- Molecular Weight: 638.80
- Catalog: Signaling Pathways GPCR/G Protein CGRP Receptor
- Create Date: 2021-12-19 11:58:43
- Modify Date: 2024-01-14 12:37:19
-
Vazegepant is the first intranasal CGRP receptor antagonist for the study the acute research of migraine[1][2].
| Name | N-{(2R)-3-(7-Methyl-1H-indazol-5-yl)-1-[4-(1-methyl-4-piperidinyl)-1-piperazinyl]-1-oxo-2-propanyl}-4-(2-oxo-1,2-dihydro-3-quinolinyl)-1-piperidinecarboxamide |
|---|---|
| Synonyms |
1-Piperidinecarboxamide, 4-(1,2-dihydro-2-oxo-3-quinolinyl)-N-[(1R)-1-[(7-methyl-1H-indazol-5-yl)methyl]-2-[4-(1-methyl-4-piperidinyl)-1-piperazinyl]-2-oxoethyl]-
N-{(2R)-3-(7-Methyl-1H-indazol-5-yl)-1-[4-(1-methyl-4-piperidinyl)-1-piperazinyl]-1-oxo-2-propanyl}-4-(2-oxo-1,2-dihydro-3-quinolinyl)-1-piperidinecarboxamide |
| Description | Vazegepant is the first intranasal CGRP receptor antagonist for the study the acute research of migraine[1][2]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 933.7±65.0 °C at 760 mmHg |
| Molecular Formula | C36H46N8O3 |
| Molecular Weight | 638.80 |
| Flash Point | 518.5±34.3 °C |
| Exact Mass | 638.369263 |
| LogP | 4.30 |
| Vapour Pressure | 0.0±0.3 mmHg at 25°C |
| Index of Refraction | 1.648 |